The effect of doxapram on brain imaging in patients with panic disorder

Amir Garakani, Monte S. Buchsbaum, Randall E. Newmark, Chelain Goodman, Cindy J. Aaronson, Jose M. Martinez, Yuliya Torosjan, King Wai Chu, Jack M. Gorman

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Abstract

Administration of doxapram hydrochloride, a respiratory stimulant, is experienced by panic disorder patients to be similar to panic attacks but has reduced emotional effect in normal volunteers, thus providing a laboratory model of panic for functional imaging. Six panic patients and seven normal control subjects underwent positron emission tomography with 18F-deoxyglucose imaging after a single-blinded administration of either doxapram or a placebo saline solution. Saline and doxapram were administered on separate days in counterbalanced order. Patients showed a greater heart rate increase on doxapram relative to saline than controls, indicating differential response. On the saline placebo day, patients had greater prefrontal relative activity than controls. In response to doxapram, patients tended to decrease prefrontal activity more than controls, and increased cingulate gyrus and amygdala activity more than controls. This suggests that panic disorder patients activate frontal inhibitory centers less than controls, a tendency that may lower the threshold for panic.

Original languageEnglish (US)
Pages (from-to)672-686
Number of pages15
JournalEuropean Neuropsychopharmacology
Volume17
Issue number10
DOIs
StatePublished - Oct 2007
Externally publishedYes

Keywords

  • Amygdala
  • Doxapram
  • Neuroimaging
  • PET
  • Panic
  • Prefrontal cortex

ASJC Scopus subject areas

  • Pharmacology
  • Neurology
  • Clinical Neurology
  • Psychiatry and Mental health
  • Biological Psychiatry
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'The effect of doxapram on brain imaging in patients with panic disorder'. Together they form a unique fingerprint.

Cite this